Category: Drug Development

With experts predicting another deadly influenza pandemic in the future, Southern Research scientists are working on several fronts to help limit the death toll from a catastrophic flu outbreak that […]

Southern Research reproductive toxicology scientist Paul Bushdid, Ph.D., is working to develop a new, cost-efficient laboratory test to evaluate hazards to unborn children posed by potential medicines, chemicals and other […]

Southern Research has been awarded two contracts from the Biomedical Advanced Research and Development Authority (BARDA), which is a division of the U.S. Department of Health and Human Services’ Office […]

Since Southern Research received its first contributions for cancer research in 1946, our scientists have been working independently and with U.S. government and commercial clients to understand and work toward […]

College students from across the U.S. are getting firsthand experience with the innovative work conducted at Southern Research in the latest generation of the nonprofit’s internship program. Interns from Princeton […]

Southern Research has been awarded a new, five-year Indefinite-Delivery Indefinite-Quantity (IDIQ) contract from the National Cancer Institute to investigate the pharmacokinetic properties of antitumor and other therapeutic agents of interest […]

In 2014, Southern Research received funding from the National Institute of Allergies and Infectious Diseases (NIAID) through a multi-center U19 grant (U19AI109680) administered by the University of Alabama at Birmingham […]